InsidersTradesSigma
Follow the Heramed Limited stock price and the full insider trade history of the company, a listed issuer based in Australia. Shares are quoted on the AU market, under the authority of ASX. Operating in the Health Care sector, Heramed Limited has published 3 public disclosures. Market capitalisation: €41.7m. The latest transaction was filed on 24 July 2026 (Sale). Among the most active insiders: Timothy Chapman. The full history is openly available.
3
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
2 ops.
Sell Volume
13Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 22,311 of 29,064 companies
33.2
score / 100
Value17
Quality50
FCF yld-8.5%
Earn yld-9.6%
EV/EBITDA·
ROE-224%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 24 July 2026
Declarations3 total
3,666,666 sharesShareASXISIN AU0000028367ASX:2924-03114023-2A1685796
5,267,720 sharesShareASXISIN AU0000028367ASX:2924-03107666-2A1682269
2,500,000 sharesShareASXISIN AU0000028367ASX:2924-03082745-2A1668366
3 of 3 declarations
关于 Heramed Limited
Heramed Limited 是一家在 XASX 上市的医疗保健和制药公司。该公司专注于开发创新解决方案以改善女性健康。